Interstitial Lung Fibrosis Following COVID-19 Pneumonia

Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21

(2022) Haidong Wang et al.   LANCET

Diethylcarbamazine as potential treatment of COVID-19 lung fibrosis

(2022) Carlos Eduardo Medina-De la Garza et al.   MEDICAL HYPOTHESES

COVID-19 and corticosteroids: a narrative review

(2022) Gaber El-Saber Batiha et al.   INFLAMMOPHARMACOLOGY

The Impact of Tocilizumab on Radiological Changes Assessed by Quantitative Chest CT in Severe COVID-19 Patients

(2022) Ana-Maria-Jennifer Anghel et al.   Journal of Clinical Medicine

Post COVID-19 pulmonary fibrosis; a meta-analysis study

(2022) Bnar J. Hama Amin et al.   Annals of Medicine and Surgery

Pathophysiology of Pulmonary Fibrosis in the Context of COVID-19 and Implications for Treatment: A Narrative Review

(2022) Son Tran et al.   Cells

Pulmonary function and radiological features four months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study

(2021) Sabina A. Guler et al.   EUROPEAN RESPIRATORY JOURNAL

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

(2021) Chaolin Huang et al.   LANCET

Six-Month Follow-up Chest CT findings after Severe COVID-19 Pneumonia

(2021) Xiaoyu Han et al.   RADIOLOGY

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

(2021)   NEW ENGLAND JOURNAL OF MEDICINE

Follow-Up Study of the Chest CT Characteristics of COVID-19 Survivors Seven Months After Recovery

(2021) Mengqi Liu et al.   Frontiers in Medicine

Multidisciplinary approach for post-acute COVID-19 syndrome: time to break down the walls

(2021) David Montani et al.   EUROPEAN RESPIRATORY JOURNAL

Post-acute COVID-19 syndrome

(2021) Ani Nalbandian et al.   NATURE MEDICINE

The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT

(2021) Jia-Ni Zou et al.   PLoS One

Lung Fibrosis after COVID-19: Treatment Prospects

(2021) Evgeny Bazdyrev et al.   Pharmaceuticals

Complications after discharge with COVID-19 infection and risk factors associated with development of post-COVID pulmonary fibrosis

(2021) Dr Raminder Aul et al.   RESPIRATORY MEDICINE

Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management

(2021) Anolin Aslan et al.   Pneumonia

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

(2020) Lirong Zou et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

(2020) Qun Li et al.   NEW ENGLAND JOURNAL OF MEDICINE

Subacute Thyroiditis After Sars-COV-2 Infection

(2020) Alessandro Brancatella et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

(2020) Peter M George et al.   Lancet Respiratory Medicine

New-Onset Diabetes in Covid-19

(2020) Francesco Rubino et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pulmonary fibrosis in the aftermath of the Covid-19 era (Review)

(2020) Eirini Vasarmidi et al.   Experimental and Therapeutic Medicine

SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis

(2020) M. Victoria Delpino et al.   Frontiers in Cellular and Infection Microbiology

The potential indicators for pulmonary fibrosis in survivors of severe COVID-19

(2020) Wenhui Huang et al.   JOURNAL OF INFECTION

Pros and cons of corticosteroid therapy for COVID-19 patients

(2020) Paula Mattos-Silva et al.   RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY

Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort

(2020) David T Arnold et al.   THORAX

Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis

(2020) Young Joo Suh et al.   RADIOLOGY

Sixty-Day Outcomes Among Patients Hospitalized With COVID-19

(2020) Vineet Chopra et al.   ANNALS OF INTERNAL MEDICINE

Post covid 19 pulmonary fibrosis. Is it real threat?

(2020) Deependra Kumar Rai et al.   Indian Journal of Tuberculosis

Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis

(2019) Bridget F. Collins et al.   European Respiratory Review

Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation

(2018) Yi Li et al.   MOLECULAR IMMUNOLOGY

Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis

(2016) Elisabetta Balestro et al.   PLoS One

Endothelial Cells Recruit Macrophages and Contribute to a Fibrotic Milieu in Bleomycin Lung Injury

(2013) Heather G. Leach et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

(2011) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

TGF-β-induced epithelial-mesenchymal transition of A549 lung adenocarcinoma cells is enhanced by pro-inflammatory cytokines derived from RAW 264.7 macrophage cells

(2011) Mikiko Kawata et al.   JOURNAL OF BIOCHEMISTRY

Pulmonary fibrosis: pathogenesis, etiology and regulation

(2009) M S Wilson et al.   Mucosal Immunology

Fleischner Society: Glossary of Terms for Thoracic Imaging

(2008) David M. Hansell et al.   RADIOLOGY